Elizabeth Woo
Nessuna posizione attualmente
Profilo
Elizabeth Woo worked as an Investor Relations Officer at Biogen, Inc. from 1998 to 2009.
She then worked as a Senior Vice President of Investor and Public Relations at Poxel SA. In 2015, she worked as a Senior Vice President of Investor Relations at Flex Pharma, Inc. Ms. Woo received her undergraduate degree from the University of California, Berkeley and her MBA from Kellogg School of Management.
Precedenti posizioni note di Elizabeth Woo
Società | Posizione | Fine |
---|---|---|
BIOGEN INC. | Public Communications Contact | - |
POXEL | Investor Relations Contact | - |
Flex Pharma, Inc.
Flex Pharma, Inc. Pharmaceuticals: MajorHealth Technology Flex Pharma, Inc. operates as a clinical-stage biotechnology company. It operates through the Consumer Operations and Drug Development segments. The Consumer Operations segment includes HOTSHOT product and consumer operations. The Drug Development segment engages in the development of innovative and proprietary drug products to treat muscle cramps and spasms associated with severe neurological conditions. The company was founded by Rod MacKinnon, Bruce Bean, Christoph Westphal, Rich Aldrich, Michelle Dipp, and Jennifer M. Cermak in February 2014 and is headquartered in Boston, MA. | Investor Relations Contact | - |
Formazione di Elizabeth Woo
University of California, Berkeley | Undergraduate Degree |
Kellogg School of Management | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
BIOGEN INC. | Health Technology |
POXEL | Health Technology |
Aziende private | 1 |
---|---|
Flex Pharma, Inc.
Flex Pharma, Inc. Pharmaceuticals: MajorHealth Technology Flex Pharma, Inc. operates as a clinical-stage biotechnology company. It operates through the Consumer Operations and Drug Development segments. The Consumer Operations segment includes HOTSHOT product and consumer operations. The Drug Development segment engages in the development of innovative and proprietary drug products to treat muscle cramps and spasms associated with severe neurological conditions. The company was founded by Rod MacKinnon, Bruce Bean, Christoph Westphal, Rich Aldrich, Michelle Dipp, and Jennifer M. Cermak in February 2014 and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Elizabeth Woo